2021
DOI: 10.2147/ijgm.s288774
|View full text |Cite
|
Sign up to set email alerts
|

Feasibility of Iodine-131 6β-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case Series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
1
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 29 publications
1
1
0
1
Order By: Relevance
“…Cases ‘detected’ by the algorithm tended to have larger adrenal masses, lower aldosterone levels and frequently suppressed ACTH levels. In our experience reported here, when such cases have been identified and subjected to surgery to remove the mass after positive NP59 imaging, 33 the postoperative biochemical features are much in keeping with a true cortisol producing mass—suppressed morning cortisol and eventual rise in ACTH levels with recovery.…”
Section: Discussionsupporting
confidence: 51%
“…Cases ‘detected’ by the algorithm tended to have larger adrenal masses, lower aldosterone levels and frequently suppressed ACTH levels. In our experience reported here, when such cases have been identified and subjected to surgery to remove the mass after positive NP59 imaging, 33 the postoperative biochemical features are much in keeping with a true cortisol producing mass—suppressed morning cortisol and eventual rise in ACTH levels with recovery.…”
Section: Discussionsupporting
confidence: 51%
“…Although the gold standard lateralization procedure remains bilateral adrenal vein sampling (AVS), scintigraphy with I131-norcholesterol is preferred as it is a less invasive test [ 1 , 8 , 9 ]. This technique allows the assessment of adrenal function and can be used to differentiate between APA and IAH (unilateral adrenal uptake most likely indicates APA, and bilateral uptake suggests IAH).…”
Section: Discussionmentioning
confidence: 99%
“…С появлением ОФЭКТ/КТ в арсенале специалистов чувствительность визуализации альдостером резко возросла (81,8%) [94]. ОФЭКТ/КТ c NP-59 используется как альтернативный диагностический метод для верификации ПГА на ранней стадии заболевания, в том числе среди пациентов с атипичым и субклиническим течением (рис.1) [95][96], и может использоваться вместе с селективным венозным забором венозной крови (ССЗВК) или вместо ССЗВК в случае неинформативности или невозможности проведения последнего [94,97]. В таблице 1 отображены факторы, способные повлиять на захват NP-59.…”
Section: I-np-59 (метилнорхолестерол)unclassified